Who We Are
Aeris Therapeutics is dedicated to the development and commercialization of innovative therapies that improve the lives of patients with emphysema and other advanced lung diseases. We pursue this mission by maintaining our commitment to scientific excellence and the highest quality standards. Our company possesses a fundamental core competence in pulmonary medicine with substantial capabilities in preclinical and clinical research, product development and commercialization.
Total quality is vital to our business.
We are committed to investing in research and development and fueling innovation, delivering novel products resulting in outstanding value to patients, customers, and stakeholders.
Aeris Therapeutics is privately held, with corporate offices in
Woburn, Massachusetts, USA.